Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results Merck.com Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit CNBC Merck Stock Falls After Earnings. Keytruda Sales Top $8 Billion for First Time. Barron’s Our Q3 2025 financial results Merck.com Merck Profit Rises on Strong Keytruda Demand The Wall Street Journal Source link
Read More »